Publications

5491 Results

Randomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide versus Observation in High-Risk Pancreatic Neuroendocrine Tumors: SWOG S2104

Authors
H Soares;K Guthrie;S Ahmad;M Washington;B Ramnaraign;N Raj;C Seigel;S Bellasea;E Chiorean;A Dasari;J Strosberg;C Eng;PA Philip
Journal / Conference
ASCO Gastrointestinal Cancer Symposium (Jan 20-22, 2022, San Francisco, CA), TIPS poster session
Year
2022
Research Committee(s)
Gastrointestinal
Study Number(s)
S2104

Change in Plasma Alpha-Tocopherol Associations with Attenuated Pulmonary Function Decline and with CYP4F2 Missense Variation

Authors
J Xu;K Guertin;N Gaddis;A Agler;R Parker;J Feldman;A Kristal;K Arnold;P Goodman;C Tangen;D Hancock;P Cassano
Journal / Conference
American Journal of Clinical Nutrition Jan 18;nqac013. doi: 10.1093/ajcn/nqac013. Online ahead of print.
Year
2022
Research Committee(s)
Prevention and Epidemiology
PMID
PMID35040869
Study Number(s)
S0000C

SWOG 1318: A Phase 2 Trial of Blinatumomab Followed by POMP Maintenance in Older Patients with Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia

Authors
A Advani;A Moseley;K O'Dwyer;B Wood;M Fang;M Wieduwilt;I Aldoss;J Park;R Klisovic;M Baer;W Stock;R Bhave;M Othus;R Harvey;C Willman;M Litzow;R Stone;E Sharon;H Erba
Journal / Conference
Journal of Clinical Oncology May 10;40(14):1574-1582
Year
2022
Research Committee(s)
Leukemia
PMID
PMID35157496
PMC
PMC9084435
Study Number(s)
S1318

Diet- and Lifestyle-Based Prediction Models to Estimate Cancer Recurrence and Death in Stage III Colon Cancer Patients (Alliance)

Authors
E Cheng;C Ma;D Spiegelman;X Zhou;F Ou;D Niedzwiecki;R Mayer;R Whittom;A Hantel;A Benson;D Atienza;M Messino;H Kindler;E Giovannucci;E Van Blarigan;K Ng;C Gross;J Meyerhardt;C Fuchs
Journal / Conference
Journal of Clinical Oncology Mar 1;40(7):740-751; Jan 7;JCO2101784. doi: 10.1200/JCO.21.01784. Online ahead of print
Year
2022
Research Committee(s)
Gastrointestinal
PMID
PMID34995084
PMC
PMC8887946
Study Number(s)
C89803

Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials

Authors
J Unger;R Vaidya;K Albain;M LeBlanc;L Minasian;C Gotay;NL Henry;M Fisch;S Lee;CD Blanke;D Hershman
Journal / Conference
Journal of Clinical Oncology May 1;40(13):1474-1486
Year
2022
Research Committee(s)
Cancer Care Delivery and Symptom Control and Quality of Life
PMID
PMID35119908

CALGB/Alliance 40603: Long-term outcomes after neoadjuvant chemotherapy with or without carboplatin and bevacizumab in triple-negative breast cancer (TNBC)

Authors
J Shepherd;K Ballman;M-Y Polley;J Campbell;C Fan;S Selitsky;A Fernandez-Martinez;J Parker;K Hoadley;Z Hu;Y Li;M Soloway;P Spears;B Singh;S Tolaney;G Somlo;E Port;C Ma;C Kuzma;E Mamounas;M Golshan;J Bellon;D Collyar;O Hahn;C Hudis;E Winer;A Partridge;T Hyslop;L Carey;C Perou;W Sikov
Journal / Conference
Journal of Clinical Oncology Jan 19;JCO2101506. doi: 10.1200/JCO.21.01506. Online ahead of print
Year
2022
Research Committee(s)
Breast
PMID
PMID35044810
Study Number(s)
CTSU/C40603

Genetically-proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers

Authors
J Yarmolinsky;V Diez-Obrero;T Richardson;M Pigeyre;J Sjaarda;G Pare;V Walker;E Vincent;V Tan;M Obon-Santacana;D Albanes;J Hampe;A Gsur;H Hampel;E Kampman;R Pai;M Jenkins;S Gallinger;W Zheng;C Amos;ILCC;PRACTICAL CONSORTIUM (Tangen);G Davey;R Martin;V Moreno
Journal / Conference
PLOS Medicine Feb 3;19(2):e1003897
Year
2022
Research Committee(s)
Prevention and Epidemiology
PMID
PMID35113855
PMC
PMC8812899
Study Number(s)
S0000

Circulating Inflammatory Cytokines and Risk of Five Cancers: a Mendelian Randomization Analysis

Authors
E Bouras;V Karhunen;J Huang;D Gill;P Brennan;M Gunter;P Haycock;M Johansson;T Key;S Lewis;R Martin;F Mengaux;N Murphy;E Platz;R Travis;T Truong;J Yarmolinsky;M-R Jarvelin;A Dehghan;K Tsilidis;Contributor C Tangen
Journal / Conference
BMC Medicine Jan 11;20(1):3
Year
2022
Research Committee(s)
Cancer Control and Prevention and Epidemiology
PMID
PMID35012533
PMC
PMC8750876
Study Number(s)
S0000, SWOG-9217

The relationship between Lipoprotein A and Prostate Cancer risk: A multivariable Mendelian randomization study

Authors
A Ioannidou;E Watts;A Perez-Cornago;E Platz;I Mills;T Key;R Travis;K Tsilidis;V Zuber;Contributor C Tangen
Journal / Conference
PLOS Medicine Jan 27;19(1):e1003859. doi: 10.1371/journal.pmed.1003859. eCollection 2022 Jan
Year
2022
Research Committee(s)
Cancer Control and Prevention and Epidemiology
PMID
PMID35085228
PMC
PMC8794090
Study Number(s)
S0000, SWOG-9217

The Breast Cancer Weight Loss (BWEL) Trial (Alliance 011401): A Description of the Lifestyle Intervention

Authors
L Delahanty;T Wadden;P Goodwin;C Alfano;C Thomson;M Irwin;M Neuhouser;T Crane;E Frank;P Spears;B Gillis;D Hershman;E Paskett;W Salem;V Bernstein;V Stearns;J White;C Hudis;E Winer;L Carey;A Partridge;J Ligibel
Journal / Conference
Obesity Jan;30(1):28-38
Year
2022
Research Committee(s)
Breast
PMID
PMID34932888
Study Number(s)
CTSU/A011401